Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients
Condition(s):Advanced CancerLast Updated:December 11, 2019Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Advanced CancerLast Updated:December 11, 2019Active, not recruiting
Condition(s):Chemotherapy-induced Nausea and VomitingLast Updated:April 7, 2020Completed
Condition(s):Idiopathic GastroparesisLast Updated:September 10, 2019Terminated
Condition(s):FedLast Updated:January 5, 2012Completed
Condition(s):FastingLast Updated:January 5, 2012Completed
Condition(s):FedLast Updated:January 5, 2012Completed
Condition(s):FastingLast Updated:January 5, 2012Completed
Condition(s):Chemotherapy-induced Nausea and VomitingLast Updated:November 20, 2020Recruiting
Condition(s):Nausea; Vomiting; End Stage CancerLast Updated:September 20, 2018Recruiting
Condition(s):HeadacheLast Updated:August 20, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.